Global Neisseria meningitidis Infections Drug Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Neisseria meningitidis Infections Drug

• 1.1 Definition of Neisseria meningitidis Infections Drug
• 1.2 Neisseria meningitidis Infections Drug Segment by Type
  • 1.2.1 Global Neisseria meningitidis Infections Drug Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 MGBBP-3
  • 1.2.3 NCL-195
  • 1.2.4 TP-10
  • 1.2.5 Others
• 1.3 Neisseria meningitidis Infections Drug Segment by Applications
  • 1.3.1 Global Neisseria meningitidis Infections Drug Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.4 Global Neisseria meningitidis Infections Drug Overall Market
  • 1.4.1 Global Neisseria meningitidis Infections Drug Revenue (2014-2025)
  • 1.4.2 Global Neisseria meningitidis Infections Drug Production (2014-2025)
  • 1.4.3 North America Neisseria meningitidis Infections Drug Status and Prospect (2014-2025)
  • 1.4.4 Europe Neisseria meningitidis Infections Drug Status and Prospect (2014-2025)
  • 1.4.5 China Neisseria meningitidis Infections Drug Status and Prospect (2014-2025)
  • 1.4.6 Japan Neisseria meningitidis Infections Drug Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Neisseria meningitidis Infections Drug Status and Prospect (2014-2025)
  • 1.4.8 India Neisseria meningitidis Infections Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Neisseria meningitidis Infections Drug
• 2.3 Manufacturing Process Analysis of Neisseria meningitidis Infections Drug
• 2.4 Industry Chain Structure of Neisseria meningitidis Infections Drug

3 Development and Manufacturing Plants Analysis of Neisseria meningitidis Infections Drug

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Neisseria meningitidis Infections Drug Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Neisseria meningitidis Infections Drug
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Neisseria meningitidis Infections Drug Production and Capacity Analysis
• 4.2 Neisseria meningitidis Infections Drug Revenue Analysis
• 4.3 Neisseria meningitidis Infections Drug Price Analysis
• 4.4 Market Concentration Degree

5 Neisseria meningitidis Infections Drug Regional Market Analysis

• 5.1 Neisseria meningitidis Infections Drug Production by Regions
  • 5.1.1 Global Neisseria meningitidis Infections Drug Production by Regions
  • 5.1.2 Global Neisseria meningitidis Infections Drug Revenue by Regions
• 5.2 Neisseria meningitidis Infections Drug Consumption by Regions
• 5.3 North America Neisseria meningitidis Infections Drug Market Analysis
  • 5.3.1 North America Neisseria meningitidis Infections Drug Production
  • 5.3.2 North America Neisseria meningitidis Infections Drug Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Neisseria meningitidis Infections Drug Import and Export
• 5.4 Europe Neisseria meningitidis Infections Drug Market Analysis
  • 5.4.1 Europe Neisseria meningitidis Infections Drug Production
  • 5.4.2 Europe Neisseria meningitidis Infections Drug Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Neisseria meningitidis Infections Drug Import and Export
• 5.5 China Neisseria meningitidis Infections Drug Market Analysis
  • 5.5.1 China Neisseria meningitidis Infections Drug Production
  • 5.5.2 China Neisseria meningitidis Infections Drug Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Neisseria meningitidis Infections Drug Import and Export
• 5.6 Japan Neisseria meningitidis Infections Drug Market Analysis
  • 5.6.1 Japan Neisseria meningitidis Infections Drug Production
  • 5.6.2 Japan Neisseria meningitidis Infections Drug Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Neisseria meningitidis Infections Drug Import and Export
• 5.7 Southeast Asia Neisseria meningitidis Infections Drug Market Analysis
  • 5.7.1 Southeast Asia Neisseria meningitidis Infections Drug Production
  • 5.7.2 Southeast Asia Neisseria meningitidis Infections Drug Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Neisseria meningitidis Infections Drug Import and Export
• 5.8 India Neisseria meningitidis Infections Drug Market Analysis
  • 5.8.1 India Neisseria meningitidis Infections Drug Production
  • 5.8.2 India Neisseria meningitidis Infections Drug Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Neisseria meningitidis Infections Drug Import and Export

6 Neisseria meningitidis Infections Drug Segment Market Analysis (by Type)

• 6.1 Global Neisseria meningitidis Infections Drug Production by Type
• 6.2 Global Neisseria meningitidis Infections Drug Revenue by Type
• 6.3 Neisseria meningitidis Infections Drug Price by Type

7 Neisseria meningitidis Infections Drug Segment Market Analysis (by Application)

• 7.1 Global Neisseria meningitidis Infections Drug Consumption by Application
• 7.2 Global Neisseria meningitidis Infections Drug Consumption Market Share by Application (2014-2019)

8 Neisseria meningitidis Infections Drug Major Manufacturers Analysis

• 8.1 Beijing Minhai Biotechnology Co Ltd
  • 8.1.1 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Production Sites and Area Served
  • 8.1.2 Beijing Minhai Biotechnology Co Ltd Product Introduction, Application and Specification
  • 8.1.3 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Biological E Ltd
  • 8.2.1 Biological E Ltd Neisseria meningitidis Infections Drug Production Sites and Area Served
  • 8.2.2 Biological E Ltd Product Introduction, Application and Specification
  • 8.2.3 Biological E Ltd Neisseria meningitidis Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 China National Pharmaceutical Group Corp
  • 8.3.1 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Production Sites and Area Served
  • 8.3.2 China National Pharmaceutical Group Corp Product Introduction, Application and Specification
  • 8.3.3 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 GlaxoSmithKline Plc
  • 8.4.1 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Production Sites and Area Served
  • 8.4.2 GlaxoSmithKline Plc Product Introduction, Application and Specification
  • 8.4.3 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Griffith University
  • 8.5.1 Griffith University Neisseria meningitidis Infections Drug Production Sites and Area Served
  • 8.5.2 Griffith University Product Introduction, Application and Specification
  • 8.5.3 Griffith University Neisseria meningitidis Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 ImmunoBiology Ltd
  • 8.6.1 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Production Sites and Area Served
  • 8.6.2 ImmunoBiology Ltd Product Introduction, Application and Specification
  • 8.6.3 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 JN-International Medical Corp
  • 8.7.1 JN-International Medical Corp Neisseria meningitidis Infections Drug Production Sites and Area Served
  • 8.7.2 JN-International Medical Corp Product Introduction, Application and Specification
  • 8.7.3 JN-International Medical Corp Neisseria meningitidis Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 MGB Biopharma Ltd
  • 8.8.1 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Production Sites and Area Served
  • 8.8.2 MGB Biopharma Ltd Product Introduction, Application and Specification
  • 8.8.3 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Panacea Biotec Ltd
  • 8.9.1 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Production Sites and Area Served
  • 8.9.2 Panacea Biotec Ltd Product Introduction, Application and Specification
  • 8.9.3 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Pfizer Inc
  • 8.10.1 Pfizer Inc Neisseria meningitidis Infections Drug Production Sites and Area Served
  • 8.10.2 Pfizer Inc Product Introduction, Application and Specification
  • 8.10.3 Pfizer Inc Neisseria meningitidis Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Sanofi Pasteur SA
• 8.12 Serum Institute of India Ltd
• 8.13 Wellstat Vaccines LLC

9 Development Trend of Analysis of Neisseria meningitidis Infections Drug Market

• 9.1 Global Neisseria meningitidis Infections Drug Market Trend Analysis
  • 9.1.1 Global Neisseria meningitidis Infections Drug Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Neisseria meningitidis Infections Drug Regional Market Trend
  • 9.2.1 North America Neisseria meningitidis Infections Drug Forecast 2019-2025
  • 9.2.2 Europe Neisseria meningitidis Infections Drug Forecast 2019-2025
  • 9.2.3 China Neisseria meningitidis Infections Drug Forecast 2019-2025
  • 9.2.4 Japan Neisseria meningitidis Infections Drug Forecast 2019-2025
  • 9.2.5 Southeast Asia Neisseria meningitidis Infections Drug Forecast 2019-2025
  • 9.2.6 India Neisseria meningitidis Infections Drug Forecast 2019-2025
• 9.3 Neisseria meningitidis Infections Drug Market Trend (Product Type)
• 9.4 Neisseria meningitidis Infections Drug Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Neisseria meningitidis Infections Drug Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List